Olympus Corporation, trading on the OTC Markets under the ticker OLYMY, is a global technology company founded in Tokyo, Japan, in 1919. Originally established as a manufacturer of precision microscopes and thermometers, the company expanded its expertise into optics and reprography during the mid-20th century. Today, Olympus is best known for its innovations in medical and scientific imaging, leveraging more than a century of optical know-how to serve healthcare and research markets worldwide.
In its Medical Systems division, Olympus develops and markets a comprehensive portfolio of endoscopic solutions used in minimally invasive surgery and diagnostics. These products include flexible and rigid endoscopes, imaging processors, light sources, and surgical energy devices designed for gastrointestinal, urological, gynecological and other applications. The Scientific Solutions segment provides high-performance microscopes, industrial video endoscopes, measurement instruments and digital cameras for life sciences, materials research and industrial inspection. Through continuous investment in R&D, the company aims to enhance procedural accuracy for clinicians and deliver advanced tools to researchers probing biological and material structures.
Headquartered in Tokyo, Olympus maintains a global footprint with operations spanning the Americas, Europe, the Middle East, Africa and Asia-Pacific. Its products are sold through a combination of direct sales forces, distributors and strategic partnerships, ensuring localized support and service. The company’s senior management team, led by the president and CEO, emphasizes quality, customer focus and technological leadership as cornerstones of its corporate strategy. With a commitment to improving patient outcomes and advancing scientific discovery, Olympus continues to adapt its legacy in optics to meet evolving demands in healthcare and research.
AI Generated. May Contain Errors.